[Advantages and disadvantages of the medical treatment of Zollinger-Ellison syndrome]

Ann Ital Chir. 1992 Sep-Oct;63(5):557-62.
[Article in French]
No abstract available

MeSH terms

  • Cell Division
  • Enterochromaffin Cells / pathology
  • Histamine H2 Antagonists / therapeutic use
  • Humans
  • Octreotide / therapeutic use
  • Proton Pump Inhibitors
  • Stomach / pathology
  • Zollinger-Ellison Syndrome / pathology
  • Zollinger-Ellison Syndrome / therapy*

Substances

  • Histamine H2 Antagonists
  • Proton Pump Inhibitors
  • Octreotide